Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.690
-0.120 (-2.49%)
Aug 10, 2026, 9:59 AM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $368.27 million as of August 10, 2026. Its market cap has increased by 50.55% in one year.
Market Cap
368.27M
Enterprise Value
182.59M
1-Year Change
50.55%
Ranking
Category
Stock Price
$4.69
ChartMarket Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $368.27M, an increase of 35.71%. That is a compound annual growth rate of 11.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 368.27M | -49.19% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| C4 Therapeutics | 412.42M |
| Fennec Pharmaceuticals | 402.08M |
| Enanta Pharmaceuticals | 400.41M |
| Upstream Bio | 394.54M |
| Rocket Pharmaceuticals | 394.19M |
| Compass Therapeutics | 387.19M |
| Palisade Bio | 366.25M |
| DiaMedica Therapeutics | 363.71M |